Pain medicine (Malden, Mass.) · 2026
History of SCS and patient-focused innovations: a manufacturer's perspective on the role of technology.
СтатьяОбзорИсторическая статьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fishman Michael A, Hatheway John A, Chakravarthy Krishnan, Kallewaard Jan Willem, Abd-Elsayed Alaa, Kapural Leonardo, Li Sean, Eshraghi Yashar, Murphy Melissa, Jassal Navdeep, Staats Peter, Caylor Jacob, Grewal Prabhdeep K, Johanek Lisa M, Gamache Julia E
Аннотация
BACKGROUND: The first case study of spinal cord stimulation (SCS) for pain treatment, published in 1967, catalyzed decades of research to improve and optimize this therapy.
CONTENT OVERVIEW: This article provides an overview of the history of SCS technology, including advances made by industrial and academic innovators in lead designs, neurostimulator features, and battery chemistry. Foundational randomized controlled trials (RCTs) and a timeline of key product releases from the early 1970s are highlighted. The second half of the article discusses SCS technology advancements from a manufacturer's perspective and how they relate to improving the overall patient therapy experience.
CONCLUSIONS: Specific SCS technology advancements that have focused on the patient's needs include: The development of patient programmers, enhanced rechargeable battery technology, position-adaptive neurostimulators, full-body magnetic resonance imaging (MRI) conditionality, and sensing-based closed-loop features.
CONTENT OVERVIEW: This article provides an overview of the history of SCS technology, including advances made by industrial and academic innovators in lead designs, neurostimulator features, and battery chemistry. Foundational randomized controlled trials (RCTs) and a timeline of key product releases from the early 1970s are highlighted. The second half of the article discusses SCS technology advancements from a manufacturer's perspective and how they relate to improving the overall patient therapy experience.
CONCLUSIONS: Specific SCS technology advancements that have focused on the patient's needs include: The development of patient programmers, enhanced rechargeable battery technology, position-adaptive neurostimulators, full-body magnetic resonance imaging (MRI) conditionality, and sensing-based closed-loop features.